When Mark Gidley argued in a major antitrust case before a federal appeals court in 2018, he said the judges challenged him about the broader implications of his position that class certification should’ve been rejected in a suit accusing a drugmaker of suppressing generic competition.

“It made me really in the moment have to commit to a position that wound up in the opinion. So I think [oral argument] is super valuable,” Gidley said.